Defence Therapeutics (XCNQ:DTC) Buyback Yield % : -9.49 (As of May. 26, 2024)

View and export this data going back to 2021. Start your Free Trial

What is Defence Therapeutics Buyback Yield %?

Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.

Defence Therapeutics's current buyback yield was -9.49%.

Defence Therapeutics Buyback Yield % Historical Data

The historical data trend for Defence Therapeutics's Buyback Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Defence Therapeutics Buyback Yield % Chart

Defence Therapeutics Annual Data

Trend

Jun20

Jun21

Jun22

Buyback Yield %

-1.11

-1.50

Defence Therapeutics Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Sep23	Dec23
Buyback Yield %	Get a 7-Day Free Trial										-8.56	-0.42	-13.24	-	-1.64

Competitive Comparison of Defence Therapeutics's Buyback Yield %

For the Biotechnology subindustry, Defence Therapeutics's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Defence Therapeutics's Buyback Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Defence Therapeutics's Buyback Yield % distribution charts can be found below:

* The bar in red indicates where Defence Therapeutics's Buyback Yield % falls into.

Defence Therapeutics Buyback Yield % Calculation

Buyback yield is a measure of shareholder return.

Defence Therapeutics's Buyback Yield for the fiscal year that ended in Jun. 2022 is calculated as

Buyback Yield	=	Net Issuance of Stock			/	Market Cap
	=	- (Repurchase of Stock	+	Issuance of Stock)	/	Market Cap
	=	- (0	+	1.098)	/	73.2664
	=	-1.50%

Defence Therapeutics's annualized Buyback Yield for the quarter that ended in Dec. 2023 is calculated as

Buyback Yield	=	Net Issuance of Stock		(Annualized)			/	Market Cap
	=	- (Repurchase of Stock	+	Issuance of Stock)	*	Annualized Factor	/	Market Cap
	=	- (0	+	0.424)	*	4	/	103.614401
	=	-1.64%

In calculating the annualized quarterly data, the Repurchase of Stock and Issuance of Stock data used here is four times the quarterly (Dec. 2023) data.

Defence Therapeutics Buyback Yield % Related Terms

Thank you for viewing the detailed overview of Defence Therapeutics's Buyback Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Defence Therapeutics (XCNQ:DTC) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Defence Therapeutics Inc (XCNQ:DTC) » Definitions » Buyback Yield %

Comparable Companies

Traded in Other Exchanges

DTCFF:USA DTC:Germany

Address

200 Burrard Street, Suite 1680, Vancouver, BC, CAN, V6C3L6

Website

https://www.defencetherapeutics.com

Defence Therapeutics Inc is engaged in the development of a biological drug enhancer platform that improves the efficacy and safety of a multitude of biological/biosimilar-based pharmaceuticals used in the treatment of cancer and infectious diseases. The Company has one operating segment, being research and development.

Executives

Sarkis Meterissian

Director